Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc (KOD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,776,975
  • Shares Outstanding, K 61,848
  • Annual Sales, $ 0 K
  • Annual Income, $ -229,970 K
  • EBIT $ -234 M
  • EBITDA $ -208 M
  • 60-Month Beta 2.39
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 13.62

Options Overview Details

View History
  • Implied Volatility 94.81% (+0.07%)
  • Historical Volatility 180.87%
  • IV Percentile 3%
  • IV Rank 9.50%
  • IV High 405.58% on 04/21/25
  • IV Low 62.19% on 09/08/25
  • Expected Move (DTE 26) 7.82 (17.42%)
  • Put/Call Vol Ratio 0.09
  • Today's Volume 328
  • Volume Avg (30-Day) 1,304
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 17,100
  • Open Int (30-Day) 13,065
  • Expected Range 37.08 to 52.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.93
  • Number of Estimates 4
  • High Estimate $-0.73
  • Low Estimate $-1.07
  • Prior Year $-1.09
  • Growth Rate Est. (year over year) +14.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.00 +113.81%
on 03/24/26
46.67 -3.79%
on 04/13/26
+21.05 (+88.26%)
since 03/17/26
3-Month
20.88 +115.04%
on 02/05/26
46.67 -3.79%
on 04/13/26
+17.75 (+65.38%)
since 01/16/26
52-Week
2.81 +1,497.81%
on 05/15/25
46.67 -3.79%
on 04/13/26
+42.06 (+1,480.99%)
since 04/17/25

Most Recent Stories

More News
Kodiak Sciences: When Clinical Progress Stops Excusing the Cash Burn Rate

Barchart Research What to Expect from KOD Earnings KOD Generated April 1, 2026 Current Price $42.81 EPS Estimate $$-0.86 Consensus Rating Moderate Buy Average Move 7.69% Kodiak Sciences: When Clinical...

KOD : 44.90 (+11.11%)
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

PALO ALTO, Calif. , March 31, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended December 31,...

KOD : 44.90 (+11.11%)
Stocks Slump on Iran War and Weakness in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -1.74%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.38%. June...

AMAT : 396.94 (+1.81%)
GOOGL : 341.68 (+1.68%)
MPC : 213.69 (-5.55%)
AAPL : 270.23 (+2.59%)
B : 43.30 (+2.12%)
AVGO : 406.54 (+2.03%)
SNDK : 920.99 (+0.17%)
HL : 19.54 (+2.25%)
CDE : 20.38 (+4.46%)
ADI : 371.45 (+4.99%)
BF.B : 29.15 (-1.05%)
$IUXX : 26,672.43 (+1.29%)
Iran Ceasefire Skepticism Weighs on Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -0.64%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.05%. June E-mini S&P futures...

AMAT : 396.94 (+1.81%)
GOOGL : 341.68 (+1.68%)
SNDK : 920.99 (+0.17%)
HL : 19.54 (+2.25%)
CDE : 20.38 (+4.46%)
$IUXX : 26,672.43 (+1.29%)
ASML : 1,459.80 (+3.47%)
ZNM26 : 111-230s (+0.45%)
ESM26 : 7,161.50s (+1.19%)
STX : 547.75 (+3.00%)
WDC : 372.52 (+2.99%)
LRCX : 267.60 (+2.54%)
Stocks Fall as Crude Oil Jumps on Doubts About a Ceasefire in Iran

The S&P 500 Index ($SPX ) (SPY ) today is down -0.50%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.77%. June E-mini S&P futures...

AMAT : 396.94 (+1.81%)
B : 43.30 (+2.12%)
AVGO : 406.54 (+2.03%)
SNDK : 920.99 (+0.17%)
HL : 19.54 (+2.25%)
CDE : 20.38 (+4.46%)
$IUXX : 26,672.43 (+1.29%)
ASML : 1,459.80 (+3.47%)
ZNM26 : 111-230s (+0.45%)
ESM26 : 7,161.50s (+1.19%)
STX : 547.75 (+3.00%)
WDC : 372.52 (+2.99%)
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham

PALO ALTO, Calif. , March 26, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing...

KOD : 44.90 (+11.11%)
Kodiak Sciences Faces Critical Test as Losses Mount and Analyst Confidence Wavers

Barchart Research What to Expect from KOD Earnings KOD Generated March 25, 2026 Current Price $22.75 EPS Estimate $-1.02 Consensus Rating Moderate Buy Average Move 7.69% Kodiak Sciences Faces Critical...

KOD : 44.90 (+11.11%)
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

PALO ALTO, Calif. , Feb. 4, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 44.90 (+11.11%)
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference

PALO ALTO, Calif. , Jan. 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 44.90 (+11.11%)
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares

PALO ALTO, Calif. , Dec. 18, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 44.90 (+11.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Kodiak Sciences Inc. is a clinical stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic, high-prevalence retinal diseases, which are the major causes of blindness. The company's proprietary antibody biopolymer conjugate (ABC) platform is designed to maintain potent...

See More

Key Turning Points

3rd Resistance Point 51.28
2nd Resistance Point 48.45
1st Resistance Point 46.67
Last Price 44.90
1st Support Level 42.06
2nd Support Level 39.23
3rd Support Level 37.45

See More

52-Week High 46.67
Last Price 44.90
Fibonacci 61.8% 29.92
Fibonacci 50% 24.74
Fibonacci 38.2% 19.56
52-Week Low 2.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.